Kimia Biosciences Reports Mixed Performance in Q4 2023 Financial Results
Kimia Biosciences, a microcap pharmaceutical company, reported a flat performance in the quarter ending December 2023 with a score of -2, an improvement from the previous quarter. The company's operating profit and profit before tax were the highest in the last five quarters, indicating a positive trend. However, net sales have decreased and interest costs have increased, raising concerns for investors.
Kimia Biosciences, a microcap pharmaceutical company, recently announced its financial results for the quarter ending December 2023. The company's stock has been given a 'Sell' call by MarketsMOJO.
According to the financial report, Kimia Biosciences has shown a flat performance in the quarter, with a score of -2, which is an improvement from the previous quarter's score of -14. However, there are some positive aspects to the company's financials.
The company's operating profit (PBDIT) for the quarter was the highest in the last five quarters at Rs -1.05 crore. This shows a positive trend in the near term for the company's operating profit. The operating profit margin for the quarter was also the highest in the last five quarters at -4.02%, indicating an improvement in the company's efficiency.
The profit before tax (PBT) less other income for the quarter was also the highest in the last five quarters at Rs -3.18 crore, with a positive trend in the near term. The profit after tax (PAT) for the quarter was also the highest in the last five quarters at Rs -1.95 crore, with a positive trend in the near term. This shows that the company is becoming more profitable and creating higher earnings for its shareholders, as reflected in the earnings per share (EPS) of Rs -0.41, which is the highest in the last five quarters.
However, there are also some areas of concern for Kimia Biosciences. The net sales for the half-yearly period have decreased by -27.33% year on year, with a negative trend in the near term. Additionally, the interest cost for the quarter was the highest in the last five quarters at Rs 1.31 crore, with a 16.96% increase from the previous quarter. This could indicate increased borrowings for the company.
Overall, Kimia Biosciences has shown a mixed performance in the quarter ending December 2023. While there are some positive aspects to the financials, there are also some areas of concern that the company needs to address. Investors are advised to carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
